
National Health (NHI) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
89.3M
Gross Profit
86.4M
96.77%
Operating Income
47.9M
53.61%
Net Income
33.8M
37.87%
EPS (Diluted)
$0.74
Balance Sheet Metrics
Total Assets
2.8B
Total Liabilities
1.3B
Shareholders Equity
1.4B
Debt to Equity
0.93
Cash Flow Metrics
Operating Cash Flow
55.5M
Free Cash Flow
46.5M
Revenue & Profitability Trend
National Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 335.2M | 319.8M | 278.2M | 298.7M | 332.8M |
Cost of Goods Sold | 11.2M | 11.5M | 9.8M | 11.6M | 9.7M |
Gross Profit | 324.0M | 308.3M | 268.4M | 287.1M | 323.2M |
Gross Margin % | 96.7% | 96.4% | 96.5% | 96.1% | 97.1% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 21.8M | 19.8M | 25.3M | 19.3M | 14.6M |
Other Operating Expenses | 42.3M | 39.6M | 28.2M | - | - |
Total Operating Expenses | 64.0M | 59.4M | 53.5M | 19.3M | 14.6M |
Operating Income | 183.9M | 178.8M | 132.8M | 185.3M | 224.9M |
Operating Margin % | 54.9% | 55.9% | 47.7% | 62.0% | 67.6% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 56.1M | 55.5M | 42.4M | 48.1M | 49.5M |
Other Non-Operating Income | 12.6M | 13.8M | -22.4M | -22.4M | 13.3M |
Pre-tax Income | 136.6M | 134.5M | 65.4M | 112.0M | 185.3M |
Income Tax | - | - | - | - | - |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | 136.6M | 134.4M | 65.5M | 112.0M | 185.3M |
Net Margin % | 40.8% | 42.0% | 23.5% | 37.5% | 55.7% |
Key Metrics | |||||
EBITDA | 251.9M | 246.9M | 202.9M | 262.2M | 300.6M |
EPS (Basic) | $3.14 | $3.13 | $1.48 | $2.45 | $4.14 |
EPS (Diluted) | $3.13 | $3.13 | $1.48 | $2.44 | $4.14 |
Basic Shares Outstanding | 43844771 | 43388794 | 44774708 | 45714221 | 44696285 |
Diluted Shares Outstanding | 43844771 | 43388794 | 44774708 | 45714221 | 44696285 |
Income Statement Trend
National Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 24.3M | 22.3M | 19.3M | 37.4M | 43.3M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 93.6M | 89.6M | 81.9M | 99.4M | 98.3M |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | 396.9M | 375.2M | 383.0M | 514.8M | 446.8M |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 6.2M | 16.9M | 9.4M | 15.8M | 16.0M |
Total Non-Current Assets | 2.2B | 2.1B | 2.1B | 2.3B | 2.7B |
Total Assets | 2.6B | 2.5B | 2.5B | 2.8B | 3.1B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 37.8M | 34.3M | 25.9M | 23.2M | 25.2M |
Short-term Debt | 331.2M | 245.0M | 42.0M | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 414.4M | 324.4M | 112.0M | 70.2M | 87.6M |
Non-Current Liabilities | |||||
Long-term Debt | 814.8M | 890.1M | 1.1B | 1.2B | 1.5B |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | 8.8M | - |
Total Non-Current Liabilities | 814.8M | 890.1M | 1.1B | 1.3B | 1.5B |
Total Liabilities | 1.2B | 1.2B | 1.2B | 1.3B | 1.6B |
Equity | |||||
Common Stock | 457.0K | 434.0K | 434.0K | 459.0K | 452.0K |
Retained Earnings | 2.6B | 2.5B | 2.3B | -84.6M | -22.0M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.4B | 1.3B | 1.3B | 1.5B | 1.5B |
Key Metrics | |||||
Total Debt | 1.1B | 1.1B | 1.1B | 1.2B | 1.5B |
Working Capital | -17.4M | 50.8M | 271.0M | 444.6M | 359.2M |
Balance Sheet Composition
National Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 136.6M | 134.4M | 65.5M | 112.0M | 185.3M |
Depreciation & Amortization | 71.4M | 70.0M | 70.9M | 80.8M | 83.2M |
Stock-Based Compensation | 4.2M | 4.6M | 8.6M | 8.4M | 3.1M |
Working Capital Changes | -2.6M | 3.3M | -6.2M | -4.5M | -57.0K |
Operating Cash Flow | 221.1M | 199.7M | 211.7M | 235.8M | 253.1M |
Investing Activities | |||||
Capital Expenditures | -4.1M | -3.7M | 0 | -64.0K | -158.0K |
Acquisitions | - | - | 0 | 0 | -875.0K |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -45.0M | -25.9M | 39.4M | -4.5M | -12.8M |
Financing Activities | |||||
Share Repurchases | 0 | 0 | -152.0M | 0 | - |
Dividends Paid | -156.5M | -156.2M | -161.8M | -182.9M | -194.6M |
Debt Issuance | 449.7M | 564.0M | 225.0M | 491.8M | 305.0M |
Debt Repayment | -438.9M | -576.4M | -318.4M | -752.4M | -250.7M |
Financing Cash Flow | -13.6M | -169.7M | -401.3M | -701.0M | -113.8M |
Free Cash Flow | 203.7M | 180.7M | 185.3M | 210.8M | 232.0M |
Net Change in Cash | 162.5M | 4.0M | -150.2M | -469.7M | 126.6M |
Cash Flow Trend
National Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.78
Forward P/E
23.78
Price to Book
2.21
Price to Sales
10.11
PEG Ratio
-9.63
Profitability Ratios
Profit Margin
40.77%
Operating Margin
62.55%
Return on Equity
10.25%
Return on Assets
4.73%
Financial Health
Current Ratio
0.37
Debt to Equity
92.14
Beta
0.76
Per Share Data
EPS (TTM)
$3.14
Book Value per Share
$33.73
Revenue per Share
$7.75
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
nhi | 3.5B | 23.78 | 2.21 | 10.25% | 40.77% | 92.14 |
Welltower | 109.0B | 91.01 | 3.02 | 3.45% | 12.18% | 47.36 |
Ventas | 28.9B | 194.30 | 2.52 | 1.38% | 2.82% | 108.90 |
CareTrust REIT | 7.4B | 27.53 | 2.03 | 8.28% | 58.90% | 34.75 |
American Healthcare | 6.9B | -140.93 | 2.78 | -1.41% | -1.53% | 69.74 |
Healthcare Realty | 5.9B | 39.90 | 1.20 | -7.52% | -32.94% | 102.02 |
Financial data is updated regularly. All figures are in the company's reporting currency.